Skip to content
About
Company Overview
Our Team
Scientific Approach
Our Engineering
Our Platform
Pipeline & Programs
Our Pipeline
GNTI-122
POLARIS Study
News
Genti in the News
Publications
Conference Presentations
Contact
Locations
Careers
Toggle navigation
About
Company Overview
Our Team
Scientific Approach
Our Engineering
Our Platform
Pipeline & Programs
Our Pipeline
GNTI-122
POLARIS Study
News
Genti in the News
Publications
Conference Presentations
Contact
Locations
Careers
Genti Publication
May 13, 2025
A stable Engineered Regulatory T cell therapy platform with modular targeting for autoimmune and inflammatory disorders
Click here to download PDF
‹ Back to Publications